Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Psyence Biomedical Ltd. (PBM)

4.2750
-0.1650
(-3.72%)
At close: May 7 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
Total Revenue
0
0
0
0
Operating Expense
44,703.0070
44,233.4290
3,234.8690
1,855.9473
Operating Income
-44,703.0070
-44,233.4290
-3,234.8690
-1,855.9473
Net Non Operating Interest Income Expense
-27.0990
-50.8070
1.5540
0
Other Income Expense
-1,861.8720
-6,874.8110
26.9120
-2.2876
Pretax Income
-46,591.9780
-51,159.0470
-3,206.4030
-1,858.2349
Net Income Common Stockholders
-46,591.9790
-51,159.0480
-3,206.4030
-1,858.2349
Diluted NI Available to Com Stockholders
-46,591.9790
-51,159.0480
-3,206.4030
-1,858.2349
Basic EPS
-87.08
-586.50
-18.87
-10.93
Diluted EPS
-87.08
-586.50
-18.87
-10.93
Basic Average Shares
535.0290
86.8960
169.9360
169.9360
Diluted Average Shares
535.0290
86.8960
169.9360
169.9360
Total Expenses
44,703.0070
44,233.4290
3,234.8690
1,855.9473
Net Income from Continuing & Discontinued Operation
-46,591.9790
-51,159.0480
-3,206.4030
-1,858.2349
Normalized Income
-44,966.1570
-48,670.5780
-3,233.3150
-1,855.9473
Interest Income
--
2.1340
1.5540
0
Interest Expense
29.2330
52.9410
0
--
Net Interest Income
-27.0990
-50.8070
1.5540
0
EBIT
-46,562.7450
-51,106.1060
-3,206.4030
-1,855.9473
EBITDA
-46,560.7160
-51,105.8660
-3,206.4030
-1,855.9473
Reconciled Depreciation
2.0290
0.2400
0
--
Net Income from Continuing Operation Net Minority Interest
-46,591.9790
-51,159.0480
-3,206.4030
-1,858.2349
Total Unusual Items Excluding Goodwill
-1,625.8220
-2,488.4700
26.9120
-2.2876
Total Unusual Items
-1,625.8220
-2,488.4700
26.9120
-2.2876
Normalized EBITDA
-44,934.8940
-48,617.3960
-3,233.3150
-1,853.6597
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
3/31/2022 - 12/10/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PTIX Protagenic Therapeutics, Inc.
3.0400
-7.32%
 
SLGL Sol-Gel Technologies Ltd.
7.72
+0.78%
 
PCSA Processa Pharmaceuticals, Inc.
0.2576
-1.15%
 
ZVSA ZyVersa Therapeutics, Inc.
0.6848
+24.24%
 
SPRC SciSparc Ltd.
0.3100
-0.03%
 
IBO Impact BioMedical Inc.
0.5102
-16.33%
 
GLMD Galmed Pharmaceuticals Ltd.
1.2900
-11.64%
 
HEPA Hepion Pharmaceuticals, Inc.
0.3900
+20.41%
 
GRI GRI Bio, Inc.
1.7900
-6.28%
 
LIMN Liminatus Pharma, Inc.
6.00
-3.13%